Posted on 6 月 24, 20206/24/20
Brand Access Marketplace Dynamics: HIV
Posted on 6 月 24, 20206/24/20
Brand Access Marketplace Dynamics: Autoimmune
Posted on 6 月 9, 20206/9/20
What Canada’s IRP Changes Could Mean for the Industry
Posted on 4 月 29, 20204/29/20
Clinical Pathways and Policy to Guard Against Misaligned Incentives
Posted on 4 月 15, 20204/15/20
What kind of clinical data is required for FDA clearance of a Digital Medicine?
Posted on 4 月 10, 20204/10/20
What specifically triggers FDA regulation of a digital medicine?
Posted on 3 月 9, 20203/9/20
Evolving Processes to Manage Value-Based Contracts
Posted on 3 月 3, 20203/3/20
Realizing Value from Digital in the Healthcare Environment [Slides]
Posted on 12 月 23, 201912/23/19
ICER’s Unsupported Price Increase Assessment
Posted on 11 月 30, 201911/30/19